Apollon Wealth Management LLC increased its stake in shares of Corteva, Inc. (NYSE:CTVA – Free Report) by 16.5% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 6,213 shares of the company’s stock after buying an additional 878 shares during the quarter. Apollon Wealth Management LLC’s holdings in Corteva were worth $365,000 as of its most recent filing with the SEC.
A number of other large investors have also added to or reduced their stakes in CTVA. Kingsview Wealth Management LLC increased its holdings in Corteva by 4.1% during the first quarter. Kingsview Wealth Management LLC now owns 7,896 shares of the company’s stock worth $455,000 after buying an additional 309 shares during the last quarter. Orion Portfolio Solutions LLC increased its holdings in Corteva by 6.6% during the first quarter. Orion Portfolio Solutions LLC now owns 31,258 shares of the company’s stock worth $1,803,000 after buying an additional 1,924 shares during the last quarter. Acadian Asset Management LLC purchased a new stake in Corteva during the first quarter worth about $25,000. Covestor Ltd increased its holdings in Corteva by 370.7% during the first quarter. Covestor Ltd now owns 1,544 shares of the company’s stock worth $89,000 after buying an additional 1,216 shares during the last quarter. Finally, Davis R M Inc. increased its stake in shares of Corteva by 36.4% in the first quarter. Davis R M Inc. now owns 6,765 shares of the company’s stock worth $390,000 after purchasing an additional 1,804 shares in the last quarter. Hedge funds and other institutional investors own 81.54% of the company’s stock.
Wall Street Analyst Weigh In
Several equities analysts have recently weighed in on the stock. Wells Fargo & Company reduced their target price on shares of Corteva from $67.00 to $65.00 and set an “overweight” rating for the company in a research note on Friday, August 2nd. Morgan Stanley reiterated an “overweight” rating and issued a $65.00 target price on shares of Corteva in a research note on Tuesday, September 24th. JPMorgan Chase & Co. reduced their target price on shares of Corteva from $57.00 to $55.00 and set a “neutral” rating for the company in a research note on Friday, August 2nd. Citigroup assumed coverage on shares of Corteva in a research note on Wednesday, October 23rd. They issued a “buy” rating and a $68.00 target price for the company. Finally, Oppenheimer reiterated an “outperform” rating and issued a $70.00 target price (up previously from $69.00) on shares of Corteva in a research note on Friday, November 8th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $63.68.
Corteva Trading Down 3.8 %
Shares of Corteva stock opened at $55.21 on Monday. The firm has a market cap of $37.95 billion, a PE ratio of 55.77, a PEG ratio of 1.77 and a beta of 0.77. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.50 and a quick ratio of 0.96. Corteva, Inc. has a 1 year low of $43.89 and a 1 year high of $63.75. The company has a 50 day simple moving average of $58.34 and a two-hundred day simple moving average of $55.69.
Corteva Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Monday, December 2nd will be issued a $0.17 dividend. The ex-dividend date is Monday, December 2nd. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.23%. Corteva’s payout ratio is 68.69%.
Corteva Profile
Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.
Featured Articles
- Five stocks we like better than Corteva
- What does consumer price index measure?
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Breakout Stocks: What They Are and How to Identify Them
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- What is the Dogs of the Dow Strategy? Overview and Examples
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.